FDA division monitoring most drugs under the Food, Drug, and Cosmetic Act
This week has seen several medical research and regulatory developments: a mid‑stage trial has reported that Insilico Medicine's experimental drug rentosertib altered blood‑protein patterns that aging clocks read as three to four years younger; Stanford teams have published studies implanting human cortical organoids into mice and showing separate developmental origins for hindbrain neurons; and US regulators have named permanent directors for three FDA centers, stabilising leadership after months of upheaval.